Literature DB >> 9007097

The clinical phenotype of two missense mutations in the presenilin I gene in Japanese patients.

M Ikeda1, V Sharma, S M Sumi, E A Rogaeva, P Poorkaj, R Sherrington, L Nee, T Tsuda, N Oda, M Watanabe, M Aoki, M Shoji, K Abe, Y Itoyama, S Hirai, G D Schellenberg, T D Bird, P H St George-Hyslop.   

Abstract

We report the clinical and neuropathologic phenotypes associated with two different missense mutations in the presenilin 1 (PS-1) gene in Japanese patients with early-onset familial Alzheimer's disease (FAD). In the AM/JPN1 pedigree a missense mutation (C-->T) was found at nucleotide 1102, which is predicted to cause an alanine-to-valine missense substitution at codon 260. In this family, the disease had a mean age of onset of 40.3 years and an indolent course (range, 8-19 years). Neuropathologic studies in 3 members of this pedigree showed widespread senile plaques, neurofibrillary tangles, and neuronal loss, as well as abundant perivascular subpial amyloid deposits in the Virchow-Robin spaces and the presence of Pick-like intraneuronal inclusions in the dentate gyrus. In the second pedigree, transmitting a C-->T nucleotide substitution at position 1027, leading to the missense mutation of alanine to valine at codon 285, the disease had a later onset (mean, 51 years) but a more rapid course. Comparison of the disease phenotypes associated with other missense mutations in exon 9 of PS-1 reveals no clinical or pathological phenotype, which uniquely distinguishes Alzheimer's disease associated with PS-1 mutations from other forms of early-onset FAD, implying that direct mutation screening is required to identify these cases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9007097     DOI: 10.1002/ana.410400614

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

1.  Multipoint oligogenic analysis of age-at-onset data with applications to Alzheimer disease pedigrees.

Authors:  E W Daw; S C Heath; E M Wijsman
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

2.  Familial frontotemporal dementia-associated presenilin-1 c.548G>T mutation causes decreased mRNA expression and reduced presenilin function in knock-in mice.

Authors:  Hirotaka Watanabe; Dan Xia; Takahisa Kanekiyo; Raymond J Kelleher; Jie Shen
Journal:  J Neurosci       Date:  2012-04-11       Impact factor: 6.167

Review 3.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

Review 4.  Mutations, associated with early-onset Alzheimer's disease, discovered in Asian countries.

Authors:  Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2016-10-17       Impact factor: 4.458

5.  APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease.

Authors:  Vo Van Giau; Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

6.  A Targeted Gene Panel That Covers Coding, Non-coding and Short Tandem Repeat Regions Improves the Diagnosis of Patients With Neurodegenerative Diseases.

Authors:  Allen Chi-Shing Yu; Aldrin Kay-Yuen Yim; Anne Yin-Yan Chan; Liz Y P Yuen; Wing Chi Au; Timothy H T Cheng; Xiao Lin; Jing-Woei Li; Larry W L Chan; Vincent C T Mok; Ting-Fung Chan; Ho Yin Edwin Chan
Journal:  Front Neurosci       Date:  2019-12-11       Impact factor: 4.677

7.  Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP.

Authors:  Rita Joao Guerreiro; Miquel Baquero; Rafael Blesa; Mercè Boada; Jose Miguel Brás; Maria J Bullido; Ana Calado; Richard Crook; Carla Ferreira; Ana Frank; Teresa Gómez-Isla; Isabel Hernández; Alberto Lleó; Alvaro Machado; Pablo Martínez-Lage; José Masdeu; Laura Molina-Porcel; José L Molinuevo; Pau Pastor; Jordi Pérez-Tur; Rute Relvas; Catarina Resende Oliveira; Maria Helena Ribeiro; Ekaterina Rogaeva; Alfredo Sa; Lluís Samaranch; Raquel Sánchez-Valle; Isabel Santana; Lluís Tàrraga; Fernando Valdivieso; Andrew Singleton; John Hardy; Jordi Clarimón
Journal:  Neurobiol Aging       Date:  2008-07-30       Impact factor: 4.673

Review 8.  Hereditary and sporadic forms of abeta-cerebrovascular amyloidosis and relevant transgenic mouse models.

Authors:  Samir Kumar-Singh
Journal:  Int J Mol Sci       Date:  2009-04-23       Impact factor: 6.208

Review 9.  The genetics of Alzheimer's disease.

Authors:  Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2014-04-01       Impact factor: 4.458

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.